Edmond De Rothschild Holding S.A. Ionis Pharmaceuticals Inc Transaction History
Edmond De Rothschild Holding S.A.
- $6.36 Billion
- Q3 2025
A detailed history of Edmond De Rothschild Holding S.A. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 156,690 shares of IONS stock, worth $11.2 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
156,690
Previous 197,600
20.7%
Holding current value
$11.2 Million
Previous $7.81 Million
31.29%
% of portfolio
0.16%
Previous 0.13%
Shares
16 transactions
Others Institutions Holding IONS
# of Institutions
518Shares Held
155MCall Options Held
2.69MPut Options Held
1.03M-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.18 Billion0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.2MShares$941 Million0.53% of portfolio
-
Capital World Investors Los Angeles, CA12.7MShares$910 Million0.12% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$738 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.59MShares$471 Million0.08% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $10.2B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...